Philip Quirke

Q: What Schools Are Affiliated With Philip Quirke

Philip Quirke is affiliated with the following schools: Leiden University, University of York, Uppsala University, University of Leeds, Imperial College London, University of Oxford, Institute of Science Tokyo, University of Birmingham, Higher Colleges of Technology

Philip Quirke's AcademicInfluence.com Rankings

Philip Quirke

Physics

#3587

World Rank

#5061

Historical Rank

physics Degrees

Download Badge

Physics

Why Is Philip Quirke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philip Quirke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial (2005) (2852)
Summary of product characteristics (2016) (2018)
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION Histopathological Study of Lateral Tumour Spread and Surgical Excision (1986) (1891)
Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. (2007) (1444)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial (2009) (1327)
Role of circumferential margin involvement in the local recurrence of rectal cancer (1994) (1018)
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial (2009) (923)
What is the role for the circumferential margin in the modern treatment of rectal cancer? (2008) (914)
Five‐year follow‐up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer (2010) (909)
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study (2001) (873)
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. (2002) (843)
Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study (2006) (791)
Rates of Circumferential Resection Margin Involvement Vary Between Surgeons and Predict Outcomes in Rectal Cancer Surgery (2002) (638)
Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. (2010) (625)
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. (2011) (616)
Low rectal cancer: a call for a change of approach in abdominoperineal resection. (2005) (575)
Long‐term follow‐up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer (2013) (574)
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 (2017) (561)
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. (2009) (558)
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. (1998) (541)
Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone: A Prospective, Multicenter, European Study (2011) (530)
Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. (2011) (524)
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies (2014) (499)
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication (2012) (469)
The Modern Abdominoperineal Excision: The Next Challenge After Total Mesorectal Excision (2005) (438)
Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. (2007) (438)
Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. (2014) (430)
PCR: a practical approach. (1991) (429)
Mutational signature in colorectal cancer caused by genotoxic pks+E. coli (2020) (426)
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. (2014) (395)
Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. (2008) (387)
Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. (2008) (370)
Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. (2020) (370)
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer (2010) (368)
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique (2005) (367)
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. (2011) (349)
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial (2013) (349)
Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. (2012) (344)
Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer (1995) (326)
Surgical management and outcomes of colorectal cancer liver metastases (2010) (309)
Unlocking the archive – gene expression in paraffin‐embedded tissue (2001) (299)
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. (1990) (295)
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota (2017) (292)
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). (2009) (287)
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. (2008) (281)
Thirty-day postoperative mortality after colorectal cancer surgery in England (2011) (279)
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination (1988) (277)
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer (2012) (262)
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. (1993) (258)
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent (1998) (242)
Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study (2016) (238)
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. (1993) (238)
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program (2008) (234)
Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. (2010) (207)
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study (2002) (200)
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. (1993) (198)
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. (1995) (197)
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair (1999) (196)
DNA fingerprinting from single cells (1997) (192)
A uniform residual tumor (R) classification (2009) (183)
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery (2014) (181)
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. (2014) (180)
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? (2008) (177)
Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. (2014) (176)
Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. (1995) (175)
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey (2001) (174)
Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer (2012) (173)
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas (1987) (172)
p53 in colorectal cancer: clinicopathological correlation and prognostic significance (1991) (172)
Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer (2001) (169)
Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. (1994) (166)
Clinical-grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. (2020) (165)
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials (2016) (165)
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients (2010) (161)
Has the new TNM classification for colorectal cancer improved care? (2012) (159)
One millimetre is the safe cut‐off for magnetic resonance imaging prediction of surgical margin status in rectal cancer (2011) (159)
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. (1990) (158)
The future of the TNM staging system in colorectal cancer: time for a debate? (2007) (151)
PCR identification of Helicobacter pylori in faeces from gastritis patients (1993) (146)
Training and quality assurance for rectal cancer: 20 years of data is enough. (2003) (146)
Colorectal tumour deposits in the mesorectum and pericolon; a critical review (2007) (145)
Colour Normalisation in Digital Histopathology Images (2009) (142)
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program (2008) (140)
Toward routine use of 3D histopathology as a research tool. (2012) (139)
Methylation and colorectal cancer (2001) (138)
Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. (2005) (138)
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology (2007) (136)
Reporting colorectal cancer (2007) (136)
Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. (2017) (134)
Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. (2007) (132)
Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations (2010) (131)
Early gastric cancer: 46 cases treated in one surgical department. (1992) (131)
Endoluminal ultrasound and computed tomography in the staging of rectal cancer (1988) (130)
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia (2006) (130)
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial. (2009) (130)
A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study. (2009) (129)
Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer (2007) (127)
Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference (2015) (124)
Lymph nodes, tumor deposits, and TNM: are we getting better? (2011) (123)
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials (2016) (119)
Short-term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial) (2006) (118)
Helicobacter pylori infection and dental care. (1995) (116)
Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. (1985) (115)
Patients With Low Rectal Cancer Treated by Abdominoperineal Excision Have Worse Tumors and Higher Involved Margin Rates Compared With Patients Treated by Anterior Resection (2010) (113)
EphB2 is a Prognostic Factor in Colorectal Cancer (2005) (111)
MRI staging of low rectal cancer (2009) (110)
Relevance of magnetic resonance imaging‐detected pelvic sidewall lymph node involvement in rectal cancer (2011) (109)
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. (1995) (106)
Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. (1995) (104)
Significance of circumferential resection margin involvement after oesophagectomy for cancer (1993) (104)
Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour (2015) (102)
Improving the Quality of Colon Cancer Surgery Through a Surgical Education Program (2010) (99)
A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. (2011) (97)
Prediction of the response of colorectal cancer to systemic therapy. (2002) (97)
In situ validation of an intestinal stem cell signature in colorectal cancer (2012) (96)
DNA aneuploidy in ulcerative colitis. (1986) (95)
Flow cytometry: Methodology and applications in pathology (1986) (92)
DNA aneuploidy in colorectal adenomas. (1986) (92)
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning (2020) (91)
Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing (2011) (91)
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. (2013) (90)
Accuracy of radiological staging in identifying high‐risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience (2012) (90)
A Flow Cytometric, Clinical, and Histological Study of Stromal Neoplasms of the Gastrointestinal Tract (1992) (88)
Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. (2006) (87)
Parathyroid hormone-related peptide in normal human fetal development. (1990) (86)
A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme (2012) (86)
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. (1991) (85)
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling (2015) (85)
Kinetic and Physical Studies of Cell Death Induced By Chemotherapeutic Agents Or Hyperthermia (1986) (82)
Expression of DNA Double-Strand Break Repair Proteins ATM and BRCA1 Predicts Survival in Colorectal Cancer (2006) (82)
Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study (2017) (80)
Pattern of expression of c-erbB-2 oncoprotein in human fetuses. (1989) (79)
Molecular pathology of colorectal cancer. (1997) (79)
DETECTION OF MEASLES VIRUS RNA IN PARAFFIN-EMBEDDED TISSUE (1989) (79)
MRI assessment of the bony pelvis may help predict resectability of rectal cancer (2005) (76)
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer. (2016) (76)
Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study. (2006) (75)
Fixation and Spread of Somatic Mutations in Adult Human Colonic Epithelium (2018) (74)
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. (1991) (72)
Defining the surgical planes on MRI improves surgery for cancer of the low rectum. (2009) (71)
IntAct: intra‐operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trial (2018) (71)
The validity of the Royal College of Pathologists’ colorectal cancer minimum dataset within a population (2007) (71)
Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? (1986) (70)
Quality of Surgery for Stage III Colon Cancer: Comparison Between England, Germany, and Japan (2014) (69)
Simultaneous DNA 'fingerprinting', diagnosis of sex and single-gene defect status from single cells. (1995) (69)
Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. (1995) (69)
Pre‐operative staging of rectal neoplasm and its impact on clinical management (1985) (69)
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. (2014) (68)
c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. (1989) (68)
Silver‐stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma (1989) (68)
Focus on Extralevator Perineal Dissection in Supine Position for Low Rectal Cancer Has Led to Better Quality of Surgery and Oncologic Outcome (2012) (68)
Viewing apoptosis through a ‘TUNEL’ (2001) (68)
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. (1994) (66)
European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. (2020) (65)
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study (2020) (64)
High-Resolution Array Comparative Genomic Hybridization in Sporadic and Celiac Disease–Related Small Bowel Adenocarcinomas (2010) (64)
Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? (2016) (62)
The Pathologist’s Role in the Assessment of Local Recurrence in Rectal Carcinoma (1992) (62)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Quality assurance in pathology in colorectal cancer screening and diagnosis (2012) (62)
The English National Low Rectal Cancer Development Programme: key messages and future perspectives (2014) (60)
Diagnosis of molar pregnancy and persistent trophoblastic disease by flow cytometry. (1987) (59)
Cost effectiveness of antenatal screening for cystic fibrosis (1995) (59)
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. (2005) (57)
p53 expression and K-ras mutation in colorectal adenomas. (1993) (57)
Parathyroid hormone‐related peptide: Expression in fetal and neonatal development (1992) (57)
MLH1 −93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer (2008) (57)
Can a Novel MRI Staging System for Low Rectal Cancer Aid Surgical Planning? (2011) (56)
Area of Submucosal Invasion and Width of Invasion Predicts Lymph Node Metastasis in pT1 Colorectal Cancers (2015) (56)
Accurately Identifying Low‐Allelic Fraction Variants in Single Samples with Next‐Generation Sequencing: Applications in Tumor Subclone Resolution (2013) (55)
Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. (2011) (55)
The role of microsatellite instability in gastric carcinoma (1998) (55)
Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service (2016) (54)
Cancer’s craving for sugar: an opportunity for clinical exploitation (2009) (54)
Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease (2001) (54)
Multiple genetic diagnoses from single cells using multiplex PCR: reliability and allele dropout (1998) (53)
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family (1990) (53)
Evidence‐based medicine: the time has come to set standards for staging (2010) (52)
Virtual reality Powerwall versus conventional microscope for viewing pathology slides: an experimental comparison (2009) (52)
Voyaging by canoe and computer: experiments in the settlement of the Pacific Ocean (1990) (52)
Comparison of triplicated (S) and quadruplicated (W) pelvic ileal reservoirs. Studies on manovolumetry, fecal bacteriology, fecal volatile fatty acids, mucosal morphology, and functional results. (1992) (51)
Flow cytofluorometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours. (1987) (51)
DNA content and prognosis of non-Hodgkin's lymphoma. (1986) (50)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Annotations of colorectal lesions (2012) (50)
Prognostic significance of microsatellite instability in patients with gastric carcinoma. (1997) (49)
A pictorial description of extralevator abdominoperineal excision for low rectal cancer (2012) (49)
Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction. (1998) (48)
Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers (2000) (48)
Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. (2006) (48)
Molecular pathology of gastric carcinoma: progress and prospects. (1992) (48)
Prognostic indicators in centroblastic-centrocytic lymphoma. (1988) (47)
Candidate driver genes in focal chromosomal aberrations of stage II colon cancer (2010) (46)
Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients (2011) (46)
Limitations of Existing Systems of Staging for Rectal Cancer: The Forgotten Margin (1997) (46)
Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors (2007) (45)
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment (2020) (45)
Evaluation of the role of pre‐operative magnetic resonance imaging in the management of rectal cancer (2001) (44)
Prognosis and response to therapy in colorectal cancer. (2002) (44)
Tracking with virtual slides: a tool to study diagnostic error in histopathology (2009) (44)
Morphometric analysis and lymph node yield in laparoscopic complete mesocolic excision performed by supervised trainees (2014) (44)
Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells (2007) (44)
Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization (2003) (43)
Assessing the relative costs of standard open surgery and laparoscopic surgery in colorectal cancer in a randomised controlled trial in the United Kingdom. (2000) (43)
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study (2021) (42)
Magnetic resonance imaging‐detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision (2010) (42)
Virtual reality microscope versus conventional microscope regarding time to diagnosis: an experimental study (2013) (41)
Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis (2013) (41)
Acute pouchitis and deficiencies of fuel (1995) (41)
HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER (1996) (40)
RAPID SCREENING FOR ΔF508 DELETION IN CYSTIC FIBROSIS (1989) (39)
EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme (2012) (39)
Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. (1993) (39)
Direct multiplex amplification of DNA from a formalin fixed, paraffin wax embedded tissue section (2000) (39)
Correlation between epithelial cell proliferation and histological grading in gastric mucosa. (1999) (39)
Outcome measures in multimodal rectal cancer trials. (2020) (39)
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial (2017) (39)
Experimental models of colorectal cancer (1998) (38)
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia (2020) (38)
Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo‐adjuvant treatment: ‘y’‘u’ and ‘p’ need ‘mr’ and ‘ct’ (2008) (38)
Rapid Trisomy Diagnosis (21, 18, and 13) Using Fluorescent PCR and Short Tandem Repeats: Applications for Prenatal Diagnosis and Preimplantation Genetic Diagnosis (1998) (38)
Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer (1989) (37)
Population-based study of laparoscopic colorectal cancer surgery 2006–2008 (2013) (37)
Molecular biology of colorectal neoplasia. (1993) (37)
Swarm learning for decentralized artificial intelligence in cancer histopathology (2021) (37)
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. (2012) (37)
Lymphatic vessel distribution in the mucosa and submucosa and potential implications for T1 colorectal tumors. (2011) (36)
Clinicopathological, genomic and immunological factors in colorectal cancer prognosis (2018) (36)
Carcinoma of the ileostomy in a patient with familial adenomatous polyposis (1988) (36)
Fluorescent polymerase chain reaction: Part I. A new method allowing genetic diagnosis and DNA fingerprinting of single cells. (1996) (35)
Assessment of microsatellite alterations in young patients with gastric adenocarcinoma (1997) (35)
Fluorescent PCR: A new technique for PGD of sex and single-gene defects (1996) (34)
Whole mount microscopic sections reveal that Denonvilliers' fascia is one entity and adherent to the mesorectal fascia; implications for the anterior plane in total mesorectal excision? (2015) (34)
A retrospective observational study of the relationship between family history and survival from colorectal cancer (2013) (33)
Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice (2019) (33)
Sensitive, Simultaneous Quantitation of Two Unlabeled DNA Targets Using a Magnetic Nanoparticle–Enzyme Sandwich Assay (2013) (33)
Abnormal Intestinal Permeability (1987) (33)
Pathologic Processing of the Total Mesorectal Excision (2015) (32)
MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours (2011) (32)
Weakly supervised annotation‐free cancer detection and prediction of genotype in routine histopathology (2021) (32)
6003 The correlation between Topoisomerase-I (Topo1) expression and outcome of treatment with capecitabine and irinotecan in advanced colorectal cancer (ACC) patients (pts) treated in the CAIRO study of the Dutch Colorectal Cancer Group (DCCG) (2009) (31)
KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance (2012) (31)
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine? (2014) (30)
DNA Methylation, a Biomarker for Colorectal Cancer (2003) (30)
Deep learning detects genetic alterations in cancer histology generated by adversarial networks (2021) (30)
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring (2021) (30)
Modern Management of Colorectal Cancer — A Pathologist's View (2003) (30)
Goseki grading in gastric cancer: comparison with existing systems of grading and its reproducibility (1994) (30)
Comparison of treatment and outcome information between a clinical trial and the National Cancer Data Repository (2011) (30)
Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. (2001) (29)
Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma. (1987) (29)
"Let my laptop lead the way": a Middle Eastern study (2002) (29)
Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer (2016) (29)
Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). (2011) (29)
Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions (2010) (29)
A retrospective observational study of length of stay in hospital after colorectal cancer surgery in England (1998–2010) (2016) (28)
Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application (2022) (28)
Robotic-assisted surgery compared with laparoscopic resection surgery for rectal cancer: the ROLARR RCT (2019) (28)
Chromosome 5q Loss in Colorectal Flat Adenomas (2012) (28)
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum (2015) (28)
Implementation of complete mesocolic excision at a university hospital in Denmark: An audit of consecutive, prospectively collected colon cancer specimens. (2014) (26)
Internal anal sphincter nerves – a macroanatomical and microscopic description of the extrinsic autonomic nerve supply of the internal anal sphincter (2018) (26)
Understanding the surgical pitfalls in total mesorectal excision: Investigating the histology of the perirectal fascia and the pelvic autonomic nerves. (2015) (25)
Parathyroid hormone-related peptide in the human fetal uro-genital tract (1990) (25)
T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen (2012) (25)
Growth factor expression during rat development: a comparison of TGF-beta 3, TGF-alpha, bFGF, PDGF and PDGF-R. (1993) (24)
Adenoma screening and colorectal cancer. (1991) (24)
Colorectal cancer reporting: are we failing the patient? (1997) (24)
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS (2018) (24)
Pathology of colorectal cancer. (2007) (24)
Rapid genetic diagnosis at 7-9 weeks gestation: diagnosis of sex, single gene defects and DNA fingerprint from coelomic samples. (1996) (24)
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations (2017) (24)
Mesocolic plane surgery: an old but forgotten technique? (2009) (24)
Significant Individual Variation Between Pathologists in the Evaluation of Colon Cancer Specimens After Complete Mesocolic Excision (2016) (23)
TmaDB: a repository for tissue microarray data (2005) (23)
In situ hybridisation for the identification of Helicobacter pylori in paraffin wax embedded tissue. (1994) (23)
Revised staging: is it really better, or do we not know? (2010) (23)
Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non‐Hodgkin's lymphoma (1989) (23)
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial (2015) (22)
Histopathological Work-Up of Resection Specimens, Local Excisions and Biopsies in Colorectal Cancer (2012) (22)
Same day diagnosis of Down's syndrome and sex in single cells using multiplex fluorescent PCR. (1998) (22)
The new biology: histopathology (1999) (21)
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer (2017) (21)
KRAS and BRAF mutations in Nigerian colorectal cancers. (2012) (21)
Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. (2013) (21)
Hodgkin's disease: a flow cytometric study. (1988) (21)
The Design and Evaluation of Interfaces for Navigating Gigapixel Images in Digital Pathology (2016) (21)
EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review (2014) (21)
Comprehensive Mutation Analysis in Colorectal Flat Adenomas (2012) (21)
Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer (2021) (21)
Severe Symptomatic Hypoglycaemia Due to Quinine Therapy (1986) (20)
A comparison of microsatellite instability in early onset gastric carcinomas from relatively low and high incidence European populations (2000) (20)
Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia (1996) (20)
A Search for Candidate Viruses in Type 1 Diabetic Pancreas Using the Polymerase Chain Reaction (1994) (20)
Standards and datasets for reporting cancers Dataset for histopathological reporting of colorectal cancer December 2017 (2018) (20)
Intratumoral stromal morphometry predicts disease recurrence but not response to 5‐fluorouracil—results from the QUASAR trial of colorectal cancer (2018) (20)
An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. (1992) (20)
European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. (2021) (20)
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC) (2018) (20)
Challenging diagnostic issues in adenomatous polyps with epithelial misplacement in bowel cancer screening: 5 years’ experience of the Bowel Cancer Screening Programme Expert Board (2017) (20)
Biology and genetics of colorectal cancer. (2001) (20)
Quantitation by flow cytofluorometry of response of tumours of the uterine cervix to radiotherapy. (1985) (19)
The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries (2021) (19)
Performance and interaction behaviour during visual search on large, high-resolution displays (2015) (19)
Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target? (1999) (19)
Low abdominoperineal excision rates are associated with high‐workload surgeons and lower tumour height. Is further specialization needed? (2011) (18)
Diagnosis of complete molar pregnancy by microsatellites in archival material. (1993) (18)
Ischaemic proctitis and adventitial fibromuscular dysplasia of the superior rectal artery (1984) (18)
A histologic and flow cytometric study of Kaposi's sarcoma (1992) (18)
Flow cytometry of normal, hyperplastic, and malignant human endometrium. A study of ploidy and proliferative indices including comparison with in vitro S-phase labeling. (1989) (18)
Flow cytometry in persistent trophoblastic disease. (1988) (18)
Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival (2009) (18)
Urgent improvements needed to diagnose and manage Lynch syndrome (2017) (18)
Extraction and amplification of DNA from archival haematoxylin and eosin sections and cervical cytology Papanicolaou smears. (1989) (17)
No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease. (2018) (17)
Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) ‐ Pathology Standards and Datasets (2017) (17)
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis (2021) (17)
The sigmoid take-off: An anatomical imaging definition of the rectum validated on specimen analysis. (2020) (17)
Congenital Torulopsis glabrata infection in man. (1980) (17)
Experiences from the front-line routine consenting of surplus surgically removed tissue: without investment by the National Health Service fully informed consent for all is not available (2006) (17)
PROGNOSIS IN MALIGNANT GLIOMA: A RETROSPECTIVE STUDY OF BIOPSY SPECIMENS BY FLOW CYTOMETRY (1989) (17)
Deep Learning for the detection of microsatellite instability from histology images in colorectal cancer: a systematic literature review (2021) (16)
Prenatal detection of trisomy 13 from amniotic fluid by quantitative fluorescent polymerase chain reaction (1998) (16)
Examining the potential use and long-term stability of guaiac faecal occult blood test cards for microbial DNA 16S rRNA sequencing (2016) (16)
Comparison of molecular and pathologic features of stage II and stage III colon cancer in four large studies conducted for development of the 12-gene colon cancer recurrence score. (2010) (16)
New insights into the lymphovascular microanatomy of the colon and the risk of metastases in pT1 colorectal cancer obtained with quantitative methods and three‐dimensional digital reconstruction (2015) (16)
DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility. (2003) (16)
Exploring the poor outcomes of BRAF mutant (BRAF mut) advanced colorectal cancer (aCRC): Analysis from 2,530 patients (pts) in randomized clinical trials (RCTs). (2015) (16)
Preimplantation Genetic Diagnosis Using Fluorescent Polymerase Chain Reaction: Results and Future Developments (1999) (16)
Detection of Common Viruses Using the Polymerase Chain Reaction to Assess Levels of Viral Presence in Type 1 (Insulin‐dependent) Diabetic Patients (1995) (16)
Parathyroid hormone related peptide in ovarian carcinoma. (1990) (15)
DNA aneuploidy and cell proliferation in familial adenomatous polyposis. (1988) (15)
Working at the microscope: analysis of the activities involved in diagnostic pathology (2012) (15)
Flow cytofluorometric analysis of serial biopsies of tumours of the uterine cervix. (1984) (15)
Antenatal screening for cystic fibrosis (1996) (15)
Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary. (1993) (15)
Is there a case for routine clinical application of ploidy measurements in gastrointestinal tumours? (2004) (14)
Prognostic and predictive significance of proliferation in 867 colorectal cancers (2012) (14)
Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse (2016) (14)
Association between family history and mismatch repair in colorectal cancer (2005) (14)
Pathology is a necessary and informative tool in oncology clinical trials (2014) (14)
Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation (2019) (14)
Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial. (2015) (13)
Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning (2019) (13)
Morphometry of gastric carcinoma: Its association with patient survival, tumour stage, and DNA ploidy (1992) (13)
Leveraging wall-sized high-resolution displays for comparative genomics analyses of copy number variation (2013) (13)
Relationship between cell ploidy and glucocorticoid induced death in human lymphoid cell lines. (1984) (13)
The correlation between endoscopic and histopathological measurements in colorectal polyps (2015) (13)
Frequency of replication errors in colorectal cancer and their association with family history (1998) (13)
Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma (2009) (13)
Regional multidisciplinary team intervention programme to improve colorectal cancer outcomes: study protocol for the Yorkshire Cancer Research Bowel Cancer Improvement Programme (YCR BCIP) (2019) (13)
Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas (1986) (13)
Multimodal Imaging Techniques for the Extraction of Detailed Geometrical and Physiological Information for Use in Multi-Scale Models of Colorectal Cancer and Treatment of Individual Patients (2006) (12)
A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). (2015) (12)
An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results. (2005) (12)
Context Aware Colour Classification in Digital Microscopy (2011) (12)
High gastric juice ascorbic acid concentrations in members of a gastric cancer family. (1993) (11)
Comparison of FISH, PRINS, and Conventional and Fluorescent PCR for Single-Cell Sexing: Suitability for Preimplantation Genetic Diagnosis (1998) (11)
The effect of a multidisciplinary regional educational programme on the quality of colon cancer resection (2018) (11)
Acute renal failure complicating Legionnaires' disease. (1980) (11)
Extraction of DNA from exfoliative cytology specimens and its suitability for analysis by the polymerase chain reaction (1990) (11)
Detection of the Epidermal Growth Factor Receptor, Amphiregulin and Epiregulin in Formalin-Fixed Paraffin-Embedded Human Placenta Tissue by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (2013) (11)
Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in highgrade non‐Hodgkin's lymphoma (1987) (11)
Molecular markers of chemotherapeutic response and toxicity in colorectal cancer (2007) (11)
A Retrospective Observational Study of the Relationship between Single Nucleotide Polymorphisms Associated with the Risk of Developing Colorectal Cancer and Survival (2015) (10)
The anatomy of the perineal body in relation to abdominoperineal excision for low rectal cancer (2016) (10)
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC). (2020) (10)
Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel. (2020) (10)
DNA-ploidy studies in a keratocyst undergoing subsequent malignant transformation. (1987) (10)
Role of the Oxidative DNA Damage Repair Gene OGG1 in Colorectal Tumorigenesis (2013) (10)
509PDPRIMARY TUMOUR LOCATION (PTL) AS A PROGNOSTIC AND PREDICTIVE FACTOR IN ADVANCED COLORECTAL CANCER (ACRC): DATA FROM 2075 PATIENTS (PTS) IN RANDOMISED TRIALS. (2014) (10)
Quality of surgery: has the time come for colon cancer? (2015) (10)
Flow cytometry in the quantitation of DNA aneuploidy and cell proliferation in human disease. (1990) (9)
Preface to Genomic Pathology – a New Frontier (2001) (9)
Detection of c-Ki-ras mutations in bile samples from patients with pancreatic and biliary cancers (1995) (9)
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial (2021) (9)
Pathology--a molecular prognostic approach. (2002) (9)
Molecular biology and infections of the gut. (1992) (9)
Incorporating Local and Global Context for Better Automated Analysis of Colorectal Cancer on Digital Pathology Slides (2016) (9)
Mutation Detection by Clonal Sequencing of PCR Amplicons and Grouped Read Typing is Applicable to Clinical Diagnostics (2013) (9)
Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial (2019) (9)
Quantitative assessment of tumor cell density in rectal cancer following three different preoperative therapies compared to surgery alone. (2010) (8)
Rapid determination of trisomy 18 parental origin using fluorescent PCR and small tandem repeat markers: case reports (1998) (8)
INFARCTION OF THE TONGUE IN WEGENER'S GRANULOMATOSIS (1992) (8)
What can the molecular pathologist offer for optimal decision making? (2010) (8)
Prognostic value of thymidylate synthase (TS) expression on failure-free survival of fluorouracil-treated metastatic colorectal cancer patients. (2006) (8)
Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy (2021) (8)
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing (2017) (7)
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer (2020) (7)
Association of topoisomerase-1 (Topo1) with the efficacy of chemotherapy in a randomized trial for advanced colorectal cancer patients (FOCUS). (2006) (7)
Prenatal detection of trisomy 21 by fluorescent polymerase chain reaction: importance of primer selection and criticism of an earlier report. (1997) (7)
Two cases of primary malignant melanoma of the oesophagus. (1988) (7)
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer. (2017) (7)
Ex vivo specimen MRI and pathology confirm a rectosigmoid mesenteric waist at the junction of the mesorectum and mesocolon (2020) (7)
A Prototype Infrastructure for the Secure Aggregation of Imaging and Pathology Data for Colorectal Cancer Care (2006) (6)
Screening sperm donors for cystic fibrosis (1995) (6)
Combined epiregulin (EREG) and amphiregulin (AREG) expression levels as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC). (2014) (6)
Molecular approaches to colorectal cancer: a review (1998) (6)
Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: Can a regional intervention promote national change? (2020) (6)
Flat adenomas (1999) (6)
Short Term Pathology Results from the First World Wide Randomised Trial of Robotic Versus Laparoscopic Resection for Rectal Cancer (ROLARR) (2016) (6)
Towards automatic patient selection for chemotherapy in colorectal cancer trials (2014) (6)
Further applications of the polymerase chain reaction (1989) (6)
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer (2017) (6)
The polymerase chain reaction: The route to molecular histopathology (1989) (6)
Radiologist and multidisciplinary team clinician opinions on the quality of MRI rectal cancer staging reports: how are we doing? (2019) (6)
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone (2021) (6)
The modern anatomical surgical approach to localised rectal cancer (2013) (6)
Influence of age on surgical treatment and postoperative outcomes of patients with colorectal cancer in Denmark and Yorkshire, England (2021) (6)
A New Image Registration algorithm with application to 3 D Histopathology (2008) (6)
The Impact of Short Course Pre-operative Radiotherapy on Patients' Quality of Life: Data from the MRC CR07/NCIC CO16 Randomised Clinical Trial in Patients with Rectal Cancer (2008) (6)
Next Generation intraoperative Lymph node staging for Stratified colon cancer surgery (GLiSten): a multicentre, multinational feasibility study of fluorescence in predicting lymph node-positive disease (2016) (5)
Assessment of multiple markers for association with response rate (RR) and failure-free survival (FFS) in patients with advanced colorectal cancer (CRC) treated with chemotherapy in the MRC CR08 (FOCUS) randomized trial. (2004) (5)
Staging of colorectal cancer (1987) (5)
Preservation of gut microbiome following ridinilazole versus fidaxomicin treatment of Clostridium difficile infection (2017) (5)
Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer (2021) (5)
Ultrastructural study of Kaposi's sarcoma. (1996) (5)
Lynch syndrome screening in colorectal cancer: results of a prospective 2‐year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2‐million population (2021) (5)
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial (2023) (5)
Kaposi's Sarcoma: A Clinico-Pathologic Overview (1991) (5)
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer (FOCUS). (2006) (5)
Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR) (2016) (5)
GEMS–RCPSG: ‘Is Academic Medicine for Me?’ National Conference 2011, 19 November 2011 (2012) (5)
A new class of colorectal cancer gene. (1995) (5)
The role of the longitudinal muscle in the anal sphincter complex (2020) (5)
OC-074 Major improvement in the stage profile of tumours diagnosed in the NHS Bowel Cancer Screening Programme (2010) (4)
The tissue microarray data exchange specification: Extending TMA DES to provide flexible scoring and incorporate virtual slides (2011) (4)
The D prefix: toward a reproducible validated alternative end point in rectal cancer. (2015) (4)
Colon cancer surgery: pathological quality control is essential for optimal outcomes (2018) (4)
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer (2022) (4)
Prospector: A web-based tool for rapid acquisition of gold standard data for pathology research and image analysis (2015) (4)
Video. Fluorescent polymerase chain reaction: Part II. Detailed technique (1996) (4)
Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer. (2021) (4)
Encrypted federated learning for secure decentralized collaboration in cancer image analysis (2022) (4)
Polymerase chain reaction (PCR) on fixed necropsy material. (1990) (3)
Carriage of adhesive Escherichia coli after restorative proctocolectomy and pouch anal anastomosis: relation with functional outcome and inflammation. (1993) (3)
Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
Detection of somatic mutations in tumors using unaligned clonal sequencing data (2014) (3)
FOCUS 3: A study to determine the feasibility of molecular selection of therapy using K-RAS, B-RAF, and topo-1 in patients with advanced colorectal cancer (ACRC). (2012) (3)
OC-0219 THE MRC CR07 TRIAL NCIC CO16 TRIAL AFTER A MEDIAN FOLLOW UP OF 8 YEARS (2012) (3)
Characterisation of dysplastic liver nodules using low‐pass DNA sequencing and detection of chromosome arm‐level abnormalities in blood‐derived cell‐free DNA (2021) (3)
ACP Broadsheet 133: November 1992. Gross examination of the stomach. (1992) (3)
Prognostic and predictive value of tumour budding in stage II colorectal carcinoma. (2015) (3)
Molecular biology made easy. The polymerase chain reaction (1992) (3)
The molecular revolution--coming your way soon. (1992) (3)
The need for a revised staging system of metastatic (M) colorectal cancer (CRC): Evidence from a national perspective on survival following surgically treated (HPX) liver metastases. (2009) (3)
Oral Poster Presentations (2012) (3)
Reply to C. Zhuang et al. (2014) (2)
Abstract 4446: Assessment of tissue composition with digital pathology in colorectal cancer (2019) (2)
Expression of estrogen receptor β — comparison between invasive lobular and ductal cancers of the breast (2001) (2)
Extending the tissue microarray data exchange specification for inclusion of data analysis results (2011) (2)
Normal Large Intestine: Anatomy, Specimen Dissection and Histology Relevant to Pathological Practice (2012) (2)
The role of the pathologist (2005) (2)
Investigating the Faecal Microbiome in Formalin Fixed Paraffin Embedded (FFPE) Material (2015) (2)
Colorectal Cancer: Pathology for the radiologist: pathological insights into colorectal cancer (2007) (2)
Molecular markers to predict survival and benefit from adjuvant intraportal 5FU in colon cancer (1999) (2)
What is the Role of the Neutrophil: Lymphocyte Ratio in Colorectal Cancer? (2021) (2)
Hodgkin's disease: a flowcytometric study (1988) (2)
3D Histopathology of the Liver Using Dual Chromogen Histochemistry (2010) (2)
OC-033 Nine-Gene Signature Implicated in the Early Development of Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma (HCC) (2016) (2)
Tumour deposits in colorectal cancer: the challenge is continuing (2008) (2)
Quality of Surgery (2020) (2)
FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, BRAF and PIK3CA (2017) (2)
FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report. (2011) (2)
Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary Ileostomy (2021) (2)
Improving the management of early colorectal cancers (eCRC) by using quantitative markers to predict lymph node involvement and thus the need for major resection of pT1 cancers (2021) (2)
What factors determine specimen quality in colon cancer surgery? A cohort study (2020) (2)
Molecular markers and the prediction of prognosis and response to therapy in colon cancer (1999) (2)
Developing a biomarker-stratified trial design in advanced colorectal cancer: The MRC FOCUS 3 feasibility study. (2011) (2)
Blind total gastrectomy for massive bleeding from the stomach (1986) (2)
Study to identify the optimum surgical technique in colon cancer (2014) (2)
Oral nelfinavir before and during radiation therapy for rectal cancer: Changes in tumor perfusion and correlation between tissue and radiological markers of response. (2014) (2)
545P Epidermal growth factor receptor (EGFR) copy number (CN) as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC) (2017) (2)
Genomics in Colorectal Cancer: Godsend or Gimmick? (2003) (1)
Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOL (2021) (1)
Trials Symposium (2014) (1)
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision (2022) (1)
Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients (2010) (1)
EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme (2012) (1)
Pre-operative FOLFOX chemotherapy in advanced colon cancer: Pathology analysis of the FOxTROT trial (2019) (1)
Bevacizumab and combination chemotherapy in rectal cancer until surgery (BACCHUS): A phase II, multicenter, open-label, randomized study of neoadjuvant chemotherapy alone without radiation in patients with MRI-defined high-risk cancer of the rectum not threatening the circumferential margin. (2014) (1)
KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial (2012) (1)
RNA gene expression signatures and DNA copy number changes in hepatocellular carcinoma formalin-fixed paraffin-embedded archived samples compared to fresh and normal tissues from the same patients (2006) (1)
Residual Tumour Cell Density and the Relationship to Survival Following Pre-Operative Chemoradiation in Locally Advanced Rectal Cancer: Results of the NWCOG RICE Trial (2015) (1)
OP26. Assessing the relative costs of standard open surgery and laparoscopic surgery in colorectal cancer in a randomised controlled trial (1997) (1)
Fully transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study (2023) (1)
62. The virtual surgical pelvis: A highly-detailed 3D pelvic model for anatomical education and surgical simulation (2014) (1)
Gaining biomarker insights from existing stage II colorectal cancer (CRC) patient cohorts in the United Kingdom: Using real-world data to guide treatment decisions. (2017) (1)
HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC) (2015) (1)
Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC). (2014) (1)
Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study (2023) (1)
Biomodulation of irinotecan using ciclosporin: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). (2011) (1)
Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations (2022) (1)
2087 The development of a 3D anatomical atlas of the pelvis: Taking the next step in enhancing surgical anatomical education and clinical guidance (2015) (1)
Will Extralevator Abdominoperineal Excision Become the New Gold Standard (2012) (1)
Topoisomerase-1 (Topo1) as a predictive and prognostic factor in colorectal cancer chemotherapy (2009) (1)
Reduce Academic Fatigue and Enhance Retention for The Determined Ones (TDOs) in Online Learning (2021) (1)
90th Annual Convention Poster Presentations and Abstracts (1991) (1)
BACCHUS: A randomised study of neoadjuvant chemotherapy alone in patients with high-risk locally advanced rectal cancer. (2017) (1)
Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study (2022) (1)
P3.03-005 Inhibition of PRMT5 is Synthetic Lethal in Mesotheliomas Harboring MTAP Loss: Topic: Mesothelioma Transitional (2017) (1)
Oral maintenance capecitabine versus active monitoring for patients with metastatic colorectal cancer (mCRC) who are stable or responding after 16 weeks of first-line treatment: Results from the randomized FOCUS4-N trial. (2021) (1)
Exploiting Warburg's Effect for Clinical Gain: Pdk-3 is a Potential Target for Mitochondrial Modulation in Colorectal Cancer (CRC) (2010) (1)
Improving Quality of Colon Cancer Surgery Through Surgical Education (2010) (1)
Supporting Teacher Development on the Web (2008) (1)
Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies (2021) (1)
Creating Your Own Professional Development and Lifelong Learning Plan (2020) (1)
144 Quality control of rectal surgery, a must? (2009) (1)
Fostering the Role of Pathology in Research (2009) (1)
Role of derived neutrophil lymphocyte ratio as a biomarker in advanced colorectal cancer (2014) (1)
Helicobacter pylori Detection by Polymerase Chain Reaction of the Gene Encoding 16S Ribosomal RNA in Fresh and Paraffin-Embedded Material (1993) (1)
Improving the management of early colorectal cancer: assessment of quantitative markers to predict the need for major resection (2017) (1)
FOxTROT:Randomized phased II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer. (2010) (1)
The Six Best Abstracts (2018) (1)
Gastrointestinal tumors, colorectal (2012) (1)
p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms (1995) (1)
Adventitial fibromuscular dysplasia and ischaemic bowel (1984) (1)
Sustainable Leadership in a Post Pandemic HE World (2021) (0)
Reflective Writing and Its Potential for Developing Teacher Leaders (2020) (0)
Teacher Knowledge Development (2020) (0)
Online Student Teaching Practicums During COVID-19: A Successful Case in the UAE (2023) (0)
Invited commentary (2005) (0)
Action research in the Middle East and North Africa (MENA) (2023) (0)
Professional Development Learning Plans (2021) (0)
[Close teamwork between pathologist and surgeon can improve results in colorectal cancer treatment]. (2011) (0)
Developing Teachers as Leaders (2021) (0)
431P The FOCUS4-N trial results and individual patient data meta-analysis (IPDM) of maintenance therapy versus active monitoring for patients with metastatic colorectal cancer (mCRC) (2021) (0)
List of Figures and Tables (2006) (0)
Supporting English language teachers doing further degrees at a distance:a web based strategy researched (2006) (0)
How the Most Productive TESOLers Fit it all in: Strategies for Productivity and Efficiency (2020) (0)
ELT Management and Leadership Training (2020) (0)
Dr. Quirke replies (1987) (0)
A Career Impacted (2020) (0)
An Approach to Using Reflective Writing to Develop Teacher Leaders (2020) (0)
Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study (2022) (0)
Reflective Writing to Develop Teacher Leaders (2020) (0)
The Leeds Powerwall Project (LEEP) (2013) (0)
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing (2022) (0)
Analysis of membrane metallopeptidases NEPand ECE expression in prostate cancer tissue microarrays (2005) (0)
There are Significant Differences in Copy Number Variation Between Microsatellite-Stable and Instable Cases in Stage II/III Colorectal Cancer (2013) (0)
Mycobacterium paratuberculosis DNA not detected in Crohn ' s disease tissue byfluorescent polymerase chain reaction Characteristics of patients Crohn ' s Ulcerative disease colitis Controls (2006) (0)
PWE-147 Human Herpesvirus and Adenovirus Unique Genetic Sequences Detected in Hepatocellular Cancer Genomes (2013) (0)
P QUIRKE carcinoma The role of microsatellite instability in gastric (1998) (0)
Subject Index Vol. 30, Suppl. 2, 2012 (2012) (0)
Abstract 626: Cross-site reproducibility and orthogonal validation of copy number and somatic mutation calls of OncoScan® FFPE Assay Kit in solid tumors (2015) (0)
6012 POSTER DISCUSSION Improved Oncological Outcome After Modified Extralevator Abdominoperineal Excision in Low Rectal Cancer Patients (2011) (0)
Mismatch Repair Testing in Colorectal Cancer - Is Less More? (2012) (0)
Abstracts of the Association of Coloproctology of Great Britain and Ireland Annual Meeting. June 8-11, 2009. Harrogate, United Kingdom. (2009) (0)
Molecular Biology Of Digestive Disease (1994) (0)
Pathology of the mesorectum — Implications for routine reporting (1997) (0)
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling (2015) (0)
Nucleic Acids Research (0)
Chapter 5 Promoter CpG island hypermethylation patterns in polypoid and nonpolypoid colorectal adenomas (2013) (0)
Colorectal Cancer: Updated Royal College of Pathologists’ Guidelines (2015) (0)
Immunohistochemical assessment of p53 and Bcl2 does not predict response to 5-FU for colon cancer patients in the AXIS trial (2000) (0)
Patient self-reported bladder function: further information (2019) (0)
TECHNIQUES Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction (0)
Somatic Mutations of Beta2-Microglobulin are Correlated with a Lack of Disease Recurrence in a Subset of Stage II Mismatch Repair Deficient Colorectal Cancers from the QUASAR Trial (2018) (0)
A Machine Learning Model of Complete Response to Radiation in Rectal Cancer Reveals Immune Infiltrate and TGFβ Signalling as Key Predictors (2022) (0)
Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study. (2023) (0)
Storage and analysis of microarray data (2005) (0)
Assessment of rat colonic tumours by flow cytometry: Metastases are commonly DNA aneuploid (1987) (0)
End-of-trial documentation (2016) (0)
INTER-LABORATORY PRE-VALIDATION OF THE FOCUS4 PERSONALISED THERAPY TRIAL (2014) (0)
The Three-Dimensional Anatomy of the Anal Sphincter Complex and its Relevance to Low Rectal and Anal Pathology (2015) (0)
Abstracts of the Association of Coloproctology of Great Britain and Ireland Annual Meeting. July 1-3, 2012. Dublin, Ireland. (2012) (0)
Pathology and Staging (2001) (0)
09.00 -12.00 Standard of Care and Outlook to the Future in … … Colon Cancer (2013) (0)
Comparison of Mutational Status in the EGFR Pathway Across Four Different Platforms in the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial (2018) (0)
Authors' reply (1996) (0)
Are Current Automated Approaches for Determining the Phylogeny of Multiple Deposits Capable of Interpreting the Complexity of Cancer Evolution (2015) (0)
The Site of the Tumor, Not the Type of Operation, Determines the Worse Prognosis of the Low Rectal Cancer (2006) (0)
Loss of pTEN Expression is Strongly Associated with the Presence of the BRAF V600E Mutation, and Further Complicates Combination Treatment Strategies for Patients with Advanced Colorectal Cancer (2015) (0)
Diagnosis ofcomplete molar pregnancy by microsatellites inarchival material (1993) (0)
Silver jubilee of the Royal College of Pathologists (1987) (0)
Defining the Rectum and Sigmoid Colon: Should We Abolish the Term 'Rectosigmoid' to Improve Outcomes in Colorectal Cancer? (2015) (0)
5-aminolevulinic acid prescription and guidance for reconstitution (2016) (0)
Secrets from the microbiome: molecular biology meets microbiology meets histopathology … meets clinical biochemistry (2015) (0)
Investigating the poor outcomes of BRAF -mutant advanced colorectal cancer to develop practical treatment strategies (2017) (0)
Colorectal cancer (1994) (0)
HER1-3 inhibition in patients with colorectal cancer that is wild-type for BRAF, PIK3CA, KRAS, and NRAS mutations (FOCUS-4D): first results from the multi-arm multi-stage phase II/III FOCUS-4 randomised trial (2017) (0)
Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts (2022) (0)
1050 poster CHANGES IN TUMOUR PERFUSION INDUCED BY NELFINAVIR AND RADIOTHERAPY: TRANSLATION TO A PHASE I-II CLINICAL TRIAL (2011) (0)
Pathology in surgical practice. G. J. Hadfield, M. Hobsley and B. C. Morson (Eds). Edward Arnold, Maidenhead, 1985. No. of pages: ix + 500. Price: £49.50. ISBN: 0 7131 4471 8 (1987) (0)
Lymphatic vessel distribution in the mucosa and submucosa and potential implications for T1 colorectal tumours (2010) (0)
Trial case report forms (2016) (0)
Comparison of Mutational Calls Obtained with Pyrosequencing and the Affymetrix OncoScan (R) FFPE Assay in Patients with Colon Cancer Recruited to the NCRI FOxTROT Trial (2015) (0)
Comparing Gene Copy Number Status of Receptor Tyrosine Kinase and Downstream Signalling Genes Between Oesophageal and Gastric Cancer (2017) (0)
Trials Symposium (2013) (0)
Potential of Molecular Biology in Preoperative Evaluation (1997) (0)
Posters (2010) (0)
COLORECTAL CANCER. AUTHORS' REPLY (1994) (0)
DEFICIENT MISMATCH REPAIR (DMMR) AND BRAF MUTATION (MT) STATUS IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC): A META-ANALYSIS OF THE CAIRO, CAIRO2, COIN AND FOCUS STUDIES (2012) (0)
93rd annual convention podium and poster abstracts (1994) (0)
DNA ploidy is an independent prognostic factor but not a predictive factor in sporadic colorectal cancer (2002) (0)
The isolation and characterisation of circulating tumour cells from patients with hepatocellular carcinoma (2016) (0)
Artificial intelligence-assisted evaluation of tumor infiltrating CD3+ and CD8+ T cells for prognostication and prediction of benefit from adjuvant chemotherapy in early stage colorectal cancer (CRC): A retrospective analysis of the QUASAR trial. (2023) (0)
carcinomarole of microsatellite instability in gastric (2006) (0)
Supporting undergraduate teaching in histopathology with virtual microscopy (2006) (0)
The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. (2022) (0)
Will the Extra Levator Approach for Low Rectal Cancer Become the New Gold Standard (2018) (0)
MCMs and geminin: Similar expression but different relationship to survival in small bowel compared to gastric cancer (2006) (0)
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS (2018) (0)
Adenoma screening and colorectal cancer. (1991) (0)
The potential of the microbiome for colorectal cancer screening (2016) (0)
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum (2015) (0)
laparoscopic colorectal surgery so that their patients might benefit from its advantages. (2014) (0)
An Evaluation of Culture Techniques versus 16S Profiling for Investigation of Antibiotic-Mediated Alteration of Microbiota Populations within a Clinically Reflective In Vitro Model of the Human Gut (2015) (0)
Distribution and Quantification of Vessels in Normal Colorectal Tissue (2010) (0)
Reply (1994) (0)
Tumor deposits in colorectal cancer: Refining their definition in the TNM system (2023) (0)
Prognostic Factors and Colorectal Cancer; Markers in Context (2017) (0)
PWE-044 Inter-Tumour Heterogeneity in Hepatitis C Virus (HCV) Related Multi-Focal Hepatocellular Carcinoma (HCC) (2016) (0)
Edinburgh Research Explorer Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning (2020) (0)
ACP Broadsheet 133 Gross examination of the stomach (2004) (0)
196. Rectal pathology (2012) (0)
Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort (2002) (0)
Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT (2022) (0)
Short report Direct multiplex amplification of DNA from a formalin fixed, paraYn wax embedded tissue section (2000) (0)
THE EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS ON CLINICAL OUTCOME AND SURVIVAL IN THE FOCUS (FLUOROURACIL, OXALIPLATIN AND IRINOTECAN: USE AND SEQUENCING) CLINICAL TRIAL OF METASTATIC COLORECTAL CANCER (2016) (0)
Identifying molecular markers predictive of survival and benefit from adjuvant 5-fluorouracil in colon cancer (1998) (0)
Sa1943 Histopathologic Grading Using Poorly-Differentiated Clusters Predicts Outcome in Colorectal Carcinoma (2014) (0)
Current status of measurement of DNA content. (1987) (0)
Characterising the Gastrointestinal Microbiome in Comorbid Inflammatory Bowel Disease and Irritable Bowel Syndrome (2017) (0)
Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management? (2017) (0)
DCR1 promoter hypermethylation and response to irinotecan in metastatic colorectal cancer (2016) (0)
Clinical expert letter:: Improving the identification and management of Lynch syndrome in the UK (2017) (0)
Correspondence Dna Aneuploidy in Ulcerative Colitis (0)
Abstracts of the ESCP 9th Scientific and Annual Meeting, 24-26 September 2014, Barcelona, Spain. (2014) (0)
Authors' reply (1990) (0)
Whole genome sequencing of 2,023 colorectal cancers reveals mutational landscapes, new driver genes and immune interactions (2022) (0)
Reply to D.J. Sargent et al. (2016) (0)
What can the Pathologist Tell the Multidisciplinary Team about Rectal Cancer Resection (2008) (0)
Comparison of Histologically Normal Mucosa and Blood as Controls for Targeted Next Generation Sequencing Analysis in Patients with Colon Cancer in the NCRI FOxTROT Trial (2015) (0)
PIK3CA Mutation is Strongly Associated with K-ras 12/13 Mutation in Stage II/III Colorectal Cancer (2012) (0)
PWE-045 A Strong Correlation Exists between Morphologic and Genomic Heterogeneity in Hepatocellular Carcinoma (HCC) (2016) (0)
Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial (2012) (0)
Abstracts of the Association of Coloproctology of Great Britain and Ireland Annual Meeting. July 1-3, 2013. Liverpool, United Kingdom. (2013) (0)
Reporting colorectal cancer (2007) (0)
Genetic predisposition and abnormalities in gastric cancer (1994) (0)
Erratum : Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients (Analytical Cellular Pathology (2010) 33: 2 (95-104)) (2011) (0)
Exploring the suitability and stability of guaiac faecal occult blood test cards to isolate microbial DNA for 16srRNA sequencing (2016) (0)
189PFCγRIIa and FCγRIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial (2017) (0)
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing (2017) (0)
The Grb2 splice variant, Grb3-3, is a negative regulator of RAS activation (2022) (0)
Lunchtime Poster Presentations (2009) (0)
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia (2020) (0)
MRC CLASICC trial – Authors' reply (2005) (0)
Gastrointestinal Pathology (2012) (0)
Parathryroid hormone related peptide in normal human development (1990) (0)
16.29: Reproducibility of Left Ventricular Ejection Fraction Assessments by 64-Slice Multidetector Row Computed Tomography (2007) (0)
Whole-Mount Microscopic Sections Reveal that Denonvilliers' Fascia is One Entity and Adherent to the Mesorectal Fascia: Should we still Question the Anterior Plane in TME? (2015) (0)
THE NM23 GENE AND COLORECTAL CANCER. AUTHOR'S REPLY (1994) (0)
1041 NEXT GENERATION SEQUENCING USED TO MAP EARLY GENETIC LESIONS IN HEPATOCELLULAR CANCER PROGRESSION (2013) (0)
Genetic predisposition and abnormalities in gastric cancer : Gastric carcinogenesis (1994) (0)
MRC CLASICC trial - reply (2005) (0)
Title: Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning (2019) (0)
Exploring outcomes of RAS-mutant (RAS mut) advanced colorectal cancer (aCRC) treated with chemotherapy: Analysis from 2254 patients (pts) in randomised clinical trials (RCTs). (2016) (0)
Comparison of Mismatch Repair Protein Expression Between Biopsies and Resections in Advanced Colon Cancer from the Phase II Group of the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial (2018) (0)
Abstracts of Cardiff Pathology 2009, the Fifth Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain and Ireland. June 30-July 3, 2009. Cardiff, United Kingdom. (2009) (0)
The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries (2021) (0)
Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas (2009) (0)
The evolutionary landscape of colorectal tumorigenesis (2018) (0)
CONSIDERATIONS IN THE DEVELOPMENT AND VALIDATION OF GENOMIC TESTS FOR CANCER RECURRENCE AND TREATMENT BENEFIT (2010) (0)
6.0: Assessment of the range of normal left ventricular volumes in a patient population with normal ejection fraction and correlation with other modalities of ejection fraction estimation (2007) (0)
The Authors Reply. (2016) (0)
MCM proteins and geminin in gastric cancer: Association with prognosis, histological type, DNA ploidy and proliferation (2005) (0)
The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). (2022) (0)
University of Birmingham Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer (2017) (0)
Patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies may inform prospective clinical trials (2018) (0)
553PTHE DERIVED NEUTROPHIL LYMPHOCYTE RATIO (DNLR) AS A BIOMARKER IN ADVANCED COLORECTAL CANCER (ACRC). (2014) (0)
Implementation of a digital ecosystem to develop clinical algorithms (2019) (0)
Pre-Treatment and Post-Treatment Epidermal Growth Factor Receptor Pathway Mutations in a Prospective Phase II Trial (NWCOG EXCITE) of Cetuximab-Containing Chemoradiation in Locally Advanced Rectal Cancer (2015) (0)
Introduction to Flow Cytometry (1992) (0)
The Effect of Multidisciplinary Education on the Quality of Colon Cancer Resection (2015) (0)
An e-learning system using virtual slides (2005) (0)
Characterising the Oral and Bowel Microbiome as a Prelude to Understanding its Role in Cancer Development Using a Next Generation Sequencing Approach (2015) (0)
Commentary on Demetter et al. (2013) (0)
Clinical Practice and Management Strategy at a Coloproctology Center in South Korea (2018) (0)
A searchable online database of virtual slides. (2005) (0)
Objectives: To assess the variation in risk-adjusted 30-day post-operative mortality for colorectal cancer patients between Hospital Trusts within the English NHS. Design: Retrospective cross sectional population-based study of data extracted from the National Cancer Data Repository Setting: All pro (2016) (0)
Literature review search strategies (2016) (0)
Assay result variability during determination of mismatch repair deficiency status using immunohistochemistry: A transatlantic comparative study. (2011) (0)
Investigating the Challenges of Using Historical Formalin-Fixed Paraffin-Embedded (FFPE) Material from the MRC CR07 Rectal Cancer Trial Using the Affymetrix OncoScan (R) FFPE Assay and Next Generation Sequencing (2015) (0)
337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials (2022) (0)
DNA aneuploidy in ulcerative colitis. (1987) (0)
Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for Pseudomyxoma Peritonei : outcome in 519 patients (2013) (0)
The MERCURY II Study: Prospective Validation of a Low Rectal Cancer Assessment System Using Magnetic Resonance Imaging, and Development of a Local Recurrence Risk Stratification Model (2016) (0)
Small bowel adenocarcinomas are more similar to colorectal than gastric cancer according to their chromosomal copy number profile (2010) (0)
The use of Affymetrix OncoScan to Validate Biomarker Screening Results in Patients Enrolled in the MRC FOCUS4 Trial: The Quest to Get More, from Less (2017) (0)

This paper list is powered by the following services:

Other Resources About Philip Quirke

medhealth.leeds.ac.uk

What Schools Are Affiliated With Philip Quirke?

Philip Quirke is affiliated with the following schools: